EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

T‐cell engagers in small cell lung cancer

Alissa J Cooper iD, Jacob Sands iD

Cancer · 15.09.2026 · 132 (18)

DOI: 10.1002/cncr.70600 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer, online erschienen am 11.09.2026. Verfasst von Alissa J Cooper und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dana-Farber Cancer Institute, Boston, MA, USA. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms, T-Lymphocytes, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management of small cell lung cancer (SCLC) has been transformed by the advent of effective T‐cell engagers (TCEs), which circumvent the traditionally immunosuppressive tumor microenvironment by directly facilitating T‐cell–mediated cell lysis. Delta‐like ligand 3 (DLL3) has emerged as the predominant target for TCE development in SCLC given its high expression on tumor cells and relatively spared expression on normal tissues. Tarlatamab, a DLL3xCD3 TCE that is now an approved agent for SCLC, has revolutionized outcomes for patients with SCLC, but raises challenges in terms of toxicity management and real‐world implementation. In this review, we discuss the current landscape and future directions of DLL3‐targeting TCE in SCLC, including accumulating real‐world clinical experience, nascent investigation into patient selection and modifiers of response and resistance, and anticipated paradigm shifts as a result of ongoing clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Small Cell Lung CarcinomaLung NeoplasmsT-LymphocytesMembrane ProteinsIntracellular Signaling Peptides and ProteinsHumansTumor MicroenvironmentImmunotherapyAnimals

Stichwörter der Autor:innen

biomarkerscytokinesimmunotherapypatient selectionsmall cell lung carcinoma

Substanzen

DLL3 protein, humanMembrane ProteinsIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Dana-Farber Cancer Institute, Boston, MA, USA.

ORCID-Profile: Alissa J Cooper, Jacob Sands

Zitieren

APA

Cooper, A. J., & Sands, J. (2026). T‐cell engagers in small cell lung cancer. Cancer, 132(18). https://doi.org/10.1002/cncr.70600

Vancouver

Cooper AJ, Sands J. T‐cell engagers in small cell lung cancer. Cancer. 2026;132(18). doi:10.1002/cncr.70600

BibTeX
@article{Cooper2026,
  author = {Cooper, Alissa J and Sands, Jacob},
  title = {T‐cell engagers in small cell lung cancer},
  journal = {Cancer},
  year = {2026},
  volume = {132},
  number = {18},
  doi = {10.1002/cncr.70600}
}
Kostenlos starten →